Sharath K Bhagavatula, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Radiology, Interventional | 2 | 2017 | 460 | 0.900 |
Why?
|
Surgery, Computer-Assisted | 3 | 2020 | 1009 | 0.860 |
Why?
|
Cryosurgery | 3 | 2024 | 453 | 0.850 |
Why?
|
Microtechnology | 1 | 2019 | 72 | 0.680 |
Why?
|
Catheter Ablation | 4 | 2024 | 2746 | 0.630 |
Why?
|
Kidney Neoplasms | 5 | 2023 | 4229 | 0.610 |
Why?
|
Pneumoperitoneum, Artificial | 1 | 2017 | 40 | 0.590 |
Why?
|
Ascites | 1 | 2017 | 344 | 0.500 |
Why?
|
Ablation Techniques | 1 | 2017 | 249 | 0.500 |
Why?
|
Radiology Department, Hospital | 1 | 2017 | 412 | 0.460 |
Why?
|
Prostheses and Implants | 2 | 2021 | 1385 | 0.440 |
Why?
|
Phantoms, Imaging | 2 | 2021 | 2466 | 0.420 |
Why?
|
Radiography, Interventional | 1 | 2017 | 1095 | 0.350 |
Why?
|
Carcinoma, Renal Cell | 2 | 2023 | 3123 | 0.330 |
Why?
|
Liver Neoplasms | 2 | 2024 | 4249 | 0.270 |
Why?
|
Kidney Diseases | 1 | 2016 | 2145 | 0.260 |
Why?
|
Kidney | 2 | 2020 | 7167 | 0.250 |
Why?
|
Hemangioendothelioma, Epithelioid | 1 | 2024 | 54 | 0.230 |
Why?
|
Lenses | 1 | 2022 | 45 | 0.210 |
Why?
|
Tomography, X-Ray Computed | 5 | 2023 | 20086 | 0.210 |
Why?
|
Diagnostic Imaging | 1 | 2016 | 3507 | 0.210 |
Why?
|
Adenoma, Oxyphilic | 1 | 2023 | 143 | 0.200 |
Why?
|
Neoplasms | 5 | 2023 | 21596 | 0.200 |
Why?
|
Lens, Crystalline | 1 | 2022 | 388 | 0.190 |
Why?
|
Optical Fibers | 1 | 2020 | 138 | 0.180 |
Why?
|
Electroosmosis | 2 | 2009 | 11 | 0.170 |
Why?
|
Spectrum Analysis | 1 | 2020 | 451 | 0.160 |
Why?
|
Metal Nanoparticles | 1 | 2022 | 403 | 0.160 |
Why?
|
Needles | 1 | 2020 | 448 | 0.150 |
Why?
|
Magnetic Resonance Imaging, Cine | 2 | 2014 | 964 | 0.150 |
Why?
|
Bile Duct Neoplasms | 1 | 2023 | 567 | 0.150 |
Why?
|
Cholangiocarcinoma | 1 | 2023 | 516 | 0.150 |
Why?
|
Drug Delivery Systems | 3 | 2023 | 2217 | 0.140 |
Why?
|
Neoplasms, Experimental | 1 | 2021 | 1274 | 0.140 |
Why?
|
Magnetic Resonance Imaging | 2 | 2020 | 35342 | 0.140 |
Why?
|
Mitral Valve | 2 | 2014 | 1484 | 0.130 |
Why?
|
Echocardiography, Doppler, Pulsed | 1 | 2014 | 72 | 0.120 |
Why?
|
Ventricular Dysfunction, Left | 2 | 2014 | 2059 | 0.110 |
Why?
|
Pharmaceutical Preparations | 1 | 2021 | 1071 | 0.110 |
Why?
|
Nephrectomy | 1 | 2018 | 1049 | 0.110 |
Why?
|
Diastole | 1 | 2014 | 791 | 0.100 |
Why?
|
Microfluidic Analytical Techniques | 2 | 2009 | 828 | 0.100 |
Why?
|
Occupational Exposure | 1 | 2022 | 1794 | 0.100 |
Why?
|
Ventricular Function, Left | 2 | 2014 | 3656 | 0.100 |
Why?
|
Hemorrhage | 1 | 2023 | 3461 | 0.100 |
Why?
|
Image Interpretation, Computer-Assisted | 2 | 2014 | 3328 | 0.100 |
Why?
|
Treatment Outcome | 5 | 2024 | 62966 | 0.080 |
Why?
|
Elasticity Imaging Techniques | 1 | 2013 | 388 | 0.080 |
Why?
|
Glioma | 1 | 2023 | 3388 | 0.080 |
Why?
|
Glioblastoma | 1 | 2023 | 3456 | 0.080 |
Why?
|
Colloids | 1 | 2008 | 136 | 0.080 |
Why?
|
Ultrasonography | 1 | 2020 | 5978 | 0.080 |
Why?
|
Retrospective Studies | 8 | 2024 | 77098 | 0.070 |
Why?
|
Humans | 18 | 2024 | 742088 | 0.070 |
Why?
|
Imaging, Three-Dimensional | 2 | 2022 | 4029 | 0.070 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2014 | 1263 | 0.060 |
Why?
|
Myocardium | 2 | 2014 | 4775 | 0.060 |
Why?
|
Cautery | 1 | 2023 | 72 | 0.060 |
Why?
|
Liver Cirrhosis | 1 | 2013 | 1864 | 0.060 |
Why?
|
Ice | 1 | 2023 | 104 | 0.050 |
Why?
|
Bile Ducts, Intrahepatic | 1 | 2023 | 295 | 0.050 |
Why?
|
Heart | 1 | 2013 | 4462 | 0.050 |
Why?
|
Chickens | 1 | 2021 | 865 | 0.040 |
Why?
|
Fluoroscopy | 1 | 2023 | 924 | 0.040 |
Why?
|
Gold | 1 | 2022 | 483 | 0.040 |
Why?
|
Photons | 1 | 2022 | 587 | 0.040 |
Why?
|
Liver | 1 | 2013 | 7470 | 0.040 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 2 | 2009 | 407 | 0.040 |
Why?
|
Aged | 5 | 2023 | 162944 | 0.040 |
Why?
|
Workflow | 1 | 2021 | 846 | 0.040 |
Why?
|
Middle Aged | 6 | 2023 | 213127 | 0.040 |
Why?
|
Positron-Emission Tomography | 2 | 2023 | 6259 | 0.040 |
Why?
|
Cell Line, Tumor | 2 | 2022 | 16665 | 0.030 |
Why?
|
Reproducibility of Results | 3 | 2023 | 19862 | 0.030 |
Why?
|
Radiation Dosage | 1 | 2022 | 1927 | 0.030 |
Why?
|
Feasibility Studies | 1 | 2023 | 5062 | 0.030 |
Why?
|
Elastic Modulus | 1 | 2013 | 213 | 0.030 |
Why?
|
Endoscopy | 1 | 2022 | 1774 | 0.030 |
Why?
|
Automation | 1 | 2014 | 584 | 0.030 |
Why?
|
Female | 5 | 2023 | 379592 | 0.020 |
Why?
|
Nanoparticles | 1 | 2022 | 1902 | 0.020 |
Why?
|
Biopsy | 1 | 2023 | 6756 | 0.020 |
Why?
|
Male | 5 | 2023 | 349538 | 0.020 |
Why?
|
Motion | 1 | 2013 | 797 | 0.020 |
Why?
|
Staining and Labeling | 1 | 2013 | 1099 | 0.020 |
Why?
|
Silicon Dioxide | 1 | 2009 | 213 | 0.020 |
Why?
|
Hydroxides | 1 | 2008 | 47 | 0.020 |
Why?
|
Electromagnetic Phenomena | 1 | 2009 | 161 | 0.020 |
Why?
|
Observer Variation | 1 | 2014 | 2593 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2014 | 15056 | 0.020 |
Why?
|
Anticoagulants | 1 | 2023 | 4595 | 0.020 |
Why?
|
Myocardial Contraction | 1 | 2013 | 1585 | 0.020 |
Why?
|
Adsorption | 1 | 2008 | 201 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2023 | 12958 | 0.020 |
Why?
|
Adult | 5 | 2023 | 213712 | 0.020 |
Why?
|
Polytetrafluoroethylene | 1 | 2008 | 233 | 0.020 |
Why?
|
Electricity | 1 | 2008 | 182 | 0.020 |
Why?
|
Apoptosis | 1 | 2022 | 9715 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2023 | 57683 | 0.010 |
Why?
|
Ethanol | 1 | 2009 | 1337 | 0.010 |
Why?
|
Image Enhancement | 1 | 2013 | 2921 | 0.010 |
Why?
|
Stroke Volume | 1 | 2014 | 4983 | 0.010 |
Why?
|
Contrast Media | 1 | 2014 | 5295 | 0.010 |
Why?
|
Kinetics | 1 | 2008 | 6474 | 0.010 |
Why?
|
Animals | 2 | 2021 | 168561 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2013 | 14720 | 0.010 |
Why?
|
Mice | 1 | 2021 | 81045 | 0.010 |
Why?
|
Young Adult | 1 | 2013 | 56350 | 0.000 |
Why?
|